期刊
MOLECULAR CELL
卷 65, 期 2, 页码 260-271出版社
CELL PRESS
DOI: 10.1016/j.molcel.2016.11.015
关键词
-
资金
- DOD [BC093731]
- American Heart Association [12PRE9080003]
- National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK094968, DK058110]
- Welch Foundation [I-1800]
- Cecil H. and Ida Green Center for Reproductive Biology Sciences Endowment
Poly(ADP-ribosyl) ation (PARylation) is a post-translational modification of proteins mediated by PARP family members, such as PARP-1. Although PARylation has been studied extensively, few examples of definitive biological roles for site-specific PARylation have been reported. Here we show that C/EBP beta, a key pro-adipogenic transcription factor, is PARylated by PARP-1 on three amino acids in a conserved regulatory domain. PARylation at these sites inhibits C/EBP beta's DNA binding and transcriptional activities and attenuates adipogenesis in various genetic and cell-basedmodels. Interestingly, PARP-1 catalytic activity drops precipitously during the first 48 hr of differentiation, corresponding to a release of C/EBP beta from PARylation-mediated inhibition. This promotes the binding of C/EBPb at enhancers controlling the expression of adipogenic target genes and continued differentiation. Depletion or chemical inhibition of PARP-1, or mutation of the PARylation sites on C/EBP beta, enhances these early adipogenic events. Collectively, our results provide a clear example of how site-specific PARylation drives biological outcomes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据